Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed toward growing the horizons of cytokine-based immunotherapy, especially for cancers where cure choices remain limited. Make use of the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/occ-appoints-j-p-morgans-michael-kurd-to-board-of-directors/